Evoq Remedies Limited engages in the marketing, trading, and distribution of pharmaceutical formulations in India. The company trades in sweeteners, such as acesulfame potassium, aspartem, dextrose, erythritol, euro vanillin powder, malodextrin, miglitol, neotame, pharma sugar; amino acids, such as L- alanine, L-arginine, L-aspartic acid, L-carnitine, L-cystine, L-glutamic acids, L-glutamine, L-glutathione, L-glycine, L-isoleucine, L-lavine, L-leucine, L-ornathene, L-aspartate, L-phenylamine, L-serine, L-threonine, L-trytophan, L-tyrosine, L-lysine, N-acetyl, and L-andystine; excipients, which include aspartem, bronopol, cross carmellous sodium, cross povidone, ethyl olliate, hard peraffin, hpmc all grades, light liquid paraffin, mannitol, menthol crystal, etc.; neutraceuticals, such as alpha lipoic acid, astaxanthin, bacopa benfothiamine, betacarotene, biotin, bonistein, bovine colostrum powder, etc.; and opthalamics, which include atropine sulphate, bimatoprost, brimonidine, bromfenac, cyclopentolate, dorzolamide fluoromethelone, flurbiprofen, gatifloxacin, ketorolac tromethamine, latanoprost, loteprednol etabonate, moxifloxacin, natamycin, nepafenac, olopatadine, sulphacetamide sodium, timolol meleate, etc. It also offers ointments, such as adapalene, allantoin, avobenzone, azealic acid beclomethasone di propionate, betamethasone and salts, calamine, chlorocresol, citrimide clindamycin phoshphate, clobetasol propionate, clotrimazole, cyclosporine, fluocinolol acetonide, fusidic acid, gamabenzene, gentamycin sulphate, halobetasol, hydroquinone, etc.; and oncology drugs, such as abiraterone acetate, alfuzosin, anastrazole, axitinib azacitidine, bicalutamide, bleomycin, bosutinib, busualphan cabazitaxel amphorous, capcitabine, carboplatin, cisplatin, etc. In addition, the company offers vitamins, dairy and spice products, sterile, active pharmaceutical ingredients, and veterinary feed products. The company was incorporated in 2010 and is based in Ahmedabad, India.
Metrics to compare | EVOQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVOQPeersSector | |
---|---|---|---|---|
P/E Ratio | 48.9x | 31.8x | −0.6x | |
PEG Ratio | 9.69 | 0.24 | 0.00 | |
Price/Book | 0.9x | 4.5x | 2.6x | |
Price / LTM Sales | 3.5x | 2.8x | 3.1x | |
Upside (Analyst Target) | - | −1.1% | 56.2% | |
Fair Value Upside | Unlock | −14.6% | 7.7% | Unlock |